Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ORITAVANCIN DIPHOSPHATE for Cellulitis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 45 adverse event reports in the FDA FAERS database where ORITAVANCIN DIPHOSPHATE was used for Cellulitis.

Most Reported Side Effects for ORITAVANCIN DIPHOSPHATE

Side Effect Reports % Deaths Hosp.
Multiple use of single-use product 102 37.0% 1 13
Chills 87 31.5% 0 10
Infusion related reaction 63 22.8% 0 8
Off label use 49 17.8% 0 8
Back pain 41 14.9% 0 5
Pruritus 36 13.0% 0 1
Dyspnoea 35 12.7% 0 6
Flushing 35 12.7% 0 0
Tremor 35 12.7% 0 6
Nausea 33 12.0% 1 3
Rash 25 9.1% 0 0
Vomiting 22 8.0% 0 2
Chest pain 21 7.6% 0 5
Erythema 17 6.2% 0 0
Feeling cold 15 5.4% 0 2

Other Indications for ORITAVANCIN DIPHOSPHATE

Product used for unknown indication (159) Osteomyelitis (32) Staphylococcal infection (8) Device related infection (7)

Other Drugs Used for Cellulitis

VANCOMYCIN (652) CLINDAMYCIN (540) SULFAMETHOXAZOLE\TRIMETHOPRIM (383) CEPHALEXIN (303) LINEZOLID (224) PIPERACILLIN\TAZOBACTAM (213) CEFTRIAXONE (202) DOXYCYCLINE (181) ORITAVANCIN (176) CIPROFLOXACIN (169)

Related Pages

ORITAVANCIN DIPHOSPHATE Full Profile All Cellulitis Drugs ORITAVANCIN DIPHOSPHATE Demographics ORITAVANCIN DIPHOSPHATE Timeline